Centene Corporation (CNC)
Overview
Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
Explore More Data
Key Information
Stock Snapshot (Updated: Nov 05 04:00 PM EST)
Capital Structure (Updated: Nov 05 04:00 PM EST)
Calendar Events (Upcoming Earnings & Revenue Forecasts)
| Earnings | |
| Earnings Date | 2025-10-29 |
| Earnings Call | 2025-10-29 |
| Avg EPS Estimate | -1.1506 |
| Low EPS Estimate | -1.3017 |
| High EPS Estimate | -0.79 |
| Revenue | |
| Avg Revenue Forecast | 48,648,521,740 |
| Low Revenue Forecast | 47,553,000,000 |
| High Revenue Forecast | 49,872,860,160 |
CNC Liquidity Indicators Shows key metrics that reflect cash availability and short-term payment ability
| Field | Value | Description |
|---|---|---|
| Cash Holdings | $19,236,999,168 | Cash on hand, which directly shows a company's ability to meet short-term obligations. |
| Quick Ratio | 1.04 | The quick ratio, which excludes inventory, measures short-term solvency; a value above 1 is considered relatively safe. |
| Current Ratio | 1.084 | The current ratio, calculated as current assets divided by current liabilities; the higher the value, the better the liquidity. |
| Total Debt | $17,582,999,552 | Total liabilities, used together with cash and liquidity ratios to assess debt burden. |
CNC Profitability Indicators Shows key metrics that reflect overall earnings, margins, and core business profitability
| Field | Value | Description |
|---|---|---|
| EBITDA | $3,902,000,128 | EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization), which measures the profitability of core operations. |
| Operating Cash Flow | $4,064,000,000 | Operating cash flow, which reflects a company's cash-generating ability. |
| Free Cash Flow | $4,424,000,000 | Free cash flow, after deducting capital expenditures, which can be used for dividends or reinvestment. |
| Gross Margin | 11.72% | Gross margin; a higher value indicates stronger product profitability. |
| Operating Margin | 0.55% | Operating margin; slightly negative, indicating high operating costs. |
| Profit Margin | -3.16% | Net profit margin, which reflects overall profitability. |
CNC Leverage & Financial Health Indicators Shows key metrics that reflect debt levels, liquidity, and overall financial stability
| Field | Value | Description |
|---|---|---|
| Debt/Equity Ratio | 83.51% | Low leverage level, indicating the company has low debt pressure. |
| Total Debt | $17,582,999,552 | Used together with cash and EBITDA to assess debt-paying ability. |
CNC Growth Indicators Shows key financial metrics that reflect profitability, cash flow, and business expansion
| Field | Value | Description |
|---|---|---|
| Revenue Growth (YoY) | 21.50% | Rapid revenue growth, indicating fast business expansion. |
| Earnings Growth (YoY) | 0.00% | Significant EPS growth, indicating rapid improvement in profitability. |
Financial Data for CNC (Key ratios, margins, and cash flow)
| Field | Value | Description |
|---|---|---|
| Current Price | $36.84 | Latest stock trading price |
| Price Target (High) | $70 | Analyst highest expected price |
| Price Target (Low) | $28 | Analyst lowest expected price |
| Price Target (Average) | $39.76 | Average target price across analysts |
| Price Target (Median) | $38 | Median of target prices |
| Average Rating Score | 2.8 | Average analyst rating (1=Strong Buy, 5=Sell) |
| Consensus Recommendation | hold | Consensus rating |
| Analyst Coverage Count | 17 | Number of analysts providing estimates |
| Cash Holdings | $19,236,999,168 | Total cash held by the company |
| Cash per Share | $39.14 | Cash value per outstanding share |
| Total Debt | $17,582,999,552 | Company's total debt |
| Quick Ratio | 1.04 | Ability to cover short-term liabilities (excludes inventory) |
| Current Ratio | 1.084 | Overall short-term liquidity |
| Debt/Equity Ratio | 83.51% | Leverage ratio: Debt / Equity |
| EBITDA | $3,902,000,128 | Earnings before interest, taxes, depreciation & amortization |
| Total Revenue | $167,680,000,000 | Total company revenue |
| Revenue per Share | $338.516 | Total revenue divided by shares outstanding |
| Gross Profit | 11.72% | Revenue minus cost of goods sold |
| Return on Assets | 2.01% | Net income / Total assets |
| Return on Equity | -21.86% | Net income / Shareholder equity |
| Earnings Growth (YoY) | 0.00% | Year-over-year EPS growth |
| Revenue Growth (YoY) | 21.50% | Year-over-year revenue growth |
| Gross Margin | 11.72% | Gross profit / Total revenue |
| EBITDA Margin | 2.33% | EBITDA / Revenue |
| Operating Margin | 0.55% | Operating income / Revenue |
| Profit Margin | -3.16% | Net income / Revenue |
| Free Cash Flow | $4,424,000,000 | Cash left after capital expenditures |
| Operating Cash Flow | $4,064,000,000 | Cash from core business operations |
| Currency | USD | Reported in US dollars |
| Last Updated | 2025-11-05 | Data source from Yahoo |